Funded by the National Institute on Disability Rehabilitation and Research, this project aims to determine the efficacy of amantadine hydrochloride at improving outcome from minimally conscious and vegetative states resulting from TBI.  This is a randomized, controlled trial that takes place in the inpatient acute rehabilitation setting. 

Principal investigator: Joseph Giacino, PhD, at JFK Neuroscience Institute

Local Principal Investigator: Flora Hammond, MD